Pharmaceutical intermediates industry development prospects, pharmaceutical intermediates market situation? Pharmaceutical industry is an important part of China's national economy, and closely related to people's health, is an important industry related to the construction of a harmonious society.

Development prospect and market size analysis of pharmaceutical intermediates industry in 2022

In recent years, the state has taken a number of measures to encourage and promote the healthy development of China's pharmaceutical industry. Pharmaceutical intermediates are a kind of fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. These chemicals, which do not require a pharmaceutical manufacturing license, can be produced in ordinary chemical plants and can be used in the synthesis of medicines as long as they reach a certain grade. Intermediates are the key products of the previous process in the manufacture of API and h***e a different structure from the API. According to the provisions of China Food and Drug Administration, pharmaceutical intermediates can be regarded as pharmaceutical raw materials, and there is no need to apply for approval and batch number in accordance with pharmaceutical rules. However, for drug synthesis, the product quality needs to reach a certain level and usually needs to be audited by customers before it becomes a qualified supplier.

Pharmaceutical intermediates are in the middle of the industry chain, and the upstream and downstream of pharmaceutical intermediates are chemical raw material market and API market respectively. Chemical raw materials are mainly divided into inorganic chemical raw materials and organic chemical raw materials. Downstream is the API market.

In recent years, the pharmaceutical intermediates industry in China has been highly valued by governments at all levels and supported by national industrial policies. The state has issued a number of policies to encourage the development and innovation of pharmaceutical intermediates industry. Industrial policies such as Measures for The Supervision and Administration of Drug Production (Revised in 2020), Measures for the Administration of Drug Notes (revised in 2020) and Announcement of The Work Plan for The Reform of Registration Classification of Chemical Drugs h***e provided clear and broad market prospects for the development of pharmaceutical intermediates industry and a good production and operation environment for enterprises.

According to the "2021-2026 Pharmaceutical intermediates Industry in-depth analysis and Investment strategy research advisory report" released by The China Research Institute of Industry Research

According to statistics, in 2019, the market size of China's pharmaceutical intermediates industry was 199.6 billion yuan, down 1.04% year on year. In 2020, due to the impact of COVID-19, the global pharmaceutical market rose rapidly, and the market size of China's pharmaceutical intermediates industry will reach 209 billion yuan in 2020. It is expected that the market size of pharmaceutical intermediates in China will exceed 290 billion yuan by 2026.

In recent years, the global pharmaceutical intermediates industry high-speed development, the industry continues to shift to China, to promote the rapid development of China's pharmaceutical intermediates industry, at present our country of the basic chemical raw materials, pharmaceutical intermediates for pharmaceutical production basic self-sufficiency, only a handful of high-end intermediates need to rely on imports, at the same time, our country has become a major global pharmaceutical intermediates exporter, Generally speaking, the supply capacity of pharmaceutical intermediates in China is improving. The pharmaceutical industry has a high degree of globalization, especially the chemical API manufacturing industry has formed a stable division of labor system in the global cooperation. At present, China has become one of the largest producers of chemical API in the world. If domestic companies want to enter the European and American markets, they need to meet local regulatory requirements. Regional regulatory requirements raise the threshold for industry entry, especially for new enterprises, it takes a long time to meet both domestic and foreign regulatory requirements.

Looking to the future, our country the world's largest pharmaceutical intermediates production and export region, not only benefit from the development of the domestic medical market, also benefit from the development of the global pharmaceutical market, along with the progress of the medicine, the domestic and global pharmaceutical research production is expected to continue to grow, pharmaceutical intermediates market scale will continue to expand, on the one hand, the new vaccine production demand larger scale, On the other hand, the market demand for related drugs will also increase, which will drive the growth of the pharmaceutical intermediates market in China.

Pharmaceutical intermediates industry research report is mainly analyzed the pharmaceutical intermediates industry market size for demand, pharmaceutical intermediates, pharmaceutical intermediates market competition status and main business situation, pharmaceutical intermediates, pharmaceutical intermediates market main enterprise market share at the same time on the future development of pharmaceutical intermediates industry to make scientific prediction.